Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR: Arbidol + Oseltamivir for Severe Influenza
NCT03787459Phase 3Completed
- Sponsor
- Capital Medical University
- Start
- Jan 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of umifenovir in influenza, sponsored by Capital Medical University. Started Jan 2019; status: completed.
02
Drugs
umifenovir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03787459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787459.